Associate Professor / Immunologist @MDAndersonNews @GSBSImmunology Department of Thoracic / Head & Neck Medical Oncology https://teapaw.org/t.co/ZdQWBFernd
Houston, TX
Joined May 2015
- Tweets452
- Following325
- Followers369
- Likes1K
Pinned Tweet
Truly could not be more excited for this work to finally be published: jitc.bmj.com/content/14/7/e0…
It shows a microfluidic platform for rapid isolation of antigen-specific T cells based on their ability to engage their targets with no requirement for prior antigen identification.
A new platform developed by UT MD Anderson researchers quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells.
Read how this could potentially accelerate the creation of personalized treatments. @AReubenPhD #EndCancer spr.ly/6011BEG0NJ
Alexandre Reuben, Ph.D. retweeted
🔬 #Avidity is the new functional readout.
Dr. Reuben (@AReubenPhD @UTMDAnderson) explains how #ATTACH, a new microfluidic platform, avoids antigen‑selection bias, speeds T‑cell isolation & could potentially reshape #SolidTumor therapy.
👉️buff.ly/C08HUkv
#OncTwitter
Alexandre Reuben, Ph.D. retweeted
New #JITC article: "Unbiased avidity-based isolation of antigen-specific T cells" jitc.bmj.com/content/14/7/e0…
@AReubenPhD @ED_PhD_ @UTMDAnderson
Alexandre Reuben, Ph.D. retweeted
A new platform developed by UT MD Anderson researchers quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells.
Read how this could potentially accelerate the creation of personalized treatments. @AReubenPhD #EndCancer spr.ly/6011BEG0NJ
Alexandre Reuben, Ph.D. retweeted
We’re Hiring at MD Anderson - Alexandre Reuben, Ph.D.
@AReubenPhD
oncodaily.com/voices/alexand…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwtitter
Alexandre Reuben, Ph.D. retweeted
This webinar features @jillfeldman4 & @LauraJBook from EGFR Resisters & Dr Alexandre Reuben @AReubenPhD from MD Anderson a 2023 EGFR Resisters/@LUNGevity grant recipient Moderated by Dr. Upal Basu Roy they discuss engineering T cells to treat lung cancer
lungevity.canto.com/b/MS9BB
Alexandre Reuben, Ph.D. retweeted
Today we welcome more than 100 new students to the Graduate School. We look forward to seeing where their journeys will take them. #WeAreGSBS #orientation2024
Alexandre Reuben, Ph.D. retweeted
“By working with the patient-led advocacy groups, it’s an opportunity for me to make sure that the work we are doing in the lab has a direct impact on patient outcomes.” @AReubenPhD @MDAndersonNews Learn more: brnw.ch/21wLWhE #lcsm #lungcancer #lungevityresearch
Alexandre Reuben, Ph.D. retweeted
PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease - @ACKoongMDPhD
@ebludmir @ChadTangMD @MDAndersonNews @AlexSherryMD @tharakbathala @cara_haymaker @AReubenPhD @ACKoongMDPhD
oncodaily.com/blog/121538/
#OncoDaily #Oncology #Cancer
Alexandre Reuben, Ph.D. retweeted
🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received @US_FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! @Adaptimmune #Tcellpower
adaptimmune.com/investors-an…
We’re hiring - please reach out if you’d like to join us at @MDAndersonNews on our quest to develop new immunotherapies/cell therapies for the treatment of lung cancer.
jobs.mdanderson.org/search/j…
Alexandre Reuben, Ph.D. retweeted
Hakeem Lab is hiring a Visiting Fellow!
Come join our team @PATRU_Emory @EmoryVaccineCtr @EmoryUniversity!
At least 2 years of lab experience in Immunology or a related field. MSc preferred but not a must.
Alexandre Reuben, Ph.D. retweeted
Chad, Sarah, Brittany& Linda are all never-smokers with RET-positive #lungcancer. They are parents, siblings, friends & spouses. This is their story. #lcsm @StephenVLiu @NarjustFlorezMD @VivekSubbiah youtube.com/watch?v=UJwRfb53…
Alexandre Reuben, Ph.D. retweeted
CCIR-Immunology Trainee Seminar Series-
TOMORROW, 04/03 at 12 pm!
Imm students,
Krithikaa Rajkumar Bhanu from Dr. Michael Curran's lab @drcurran and
Emily Bontekoe from Dr. Alexandre Reuben’s lab @AReubenPhD
will be presenting their research!
Lunch will be provided.
Alexandre Reuben, Ph.D. retweeted
🚨Just published: The registration enabling clinical data set for an affinity-enhanced TCR targeting the cancer-germline antigen MAGE-4. Afami cell on track to be the *first* FDA approved TCR gene therapy and first gene therapy product for a solid cancer.
thelancet.com/journals/lance…
Alexandre Reuben, Ph.D. retweeted
1/ Do precancers in #LynchSyndrome (LS) patients generate #neoantigens that could be targetable with #vaccines to intercept #cancer development before tumor formation?
Check out our study published in @AGA_Gastro 🚨🤩
@evilarsan @FahriyeDuzagac
gastrojournal.org/article/S0…
🧵👇
Alexandre Reuben, Ph.D. retweeted
MD Anderson is home to hundreds of labs and thousands of scientists with expertise in different fields.
We asked four of them – Drs. Lauren Colbert, Emil Schueler, Aria Vaishnavi and Moran Amit – to share what inspires them. bit.ly/3IyhejQ @colbertle @DrAriaV @MoranAmit1 #EndCancer
Alexandre Reuben, Ph.D. retweeted
Together with our collaborators from @affinit_tx , we are excited to report at #AACR24 on a suite of #bestinclass #TCR therapies discovered in the Klebanoff Lab targeting the two most common driver mutations in human cancer: KRAS (G12D) and TP53 (R175). Come say hi! #Tcellpower
Alexandre Reuben, Ph.D. retweeted
Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer- @AReubenPhD
lungevity.org/blogs/using-t-…